Self-monitoring of blood glucose with a focus on analytical quality: An overview

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 7, 2010, Pages 963-972

  Kristensen, Gunn B B ^a   Sandberg, Sverre ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

analytical quality; blood glucose self monitoring; diabetes; instrument evaluation; monitoring; quality control

Indexed keywords

BLOOD GLUCOSE MONITORING; DIABETES MELLITUS; EVALUATION; GLYCEMIC CONTROL; HUMAN; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SELF MONITORING;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; HUMANS; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL;

EID: 77954230653     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.186     Document Type: Review

References (111)

1. Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med 1993;329:977-986
2. Diabetes Control and Complications Trial (DCCT) Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;44:968-983
3. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin- dependent diabetes mellitus: a randomized prospective 6- years study. Diabetes Res Clin Pract 1995;28:103-117
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853
5. Hanefeld M, Chiasson JL, Koehler C, Henkel E, Schaper F, Temelkova-Kurktschiev T. Acarbose slows progression of intima- media thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke 2004;35:1073-1078
6. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: metaanalysis of 37 prospective cohort studies. Br Med J 2006;332: 73-78
7. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653
8. Stettler C, Allemann S, Juni P, Cull CA, Holman RR, Egger M, et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials. Am Heart J 2006;152:27-38.
9. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 2000;321: 405-412
10. Klonoff DC. Benefits and limitations of self-monitoring of blood glucose. J Diabetes Sci Technol 2004;1:130-132
11. Drash A. The control of diabetes mellitus: is it achievable? Is it desirable? J Pediatr 1976;88:1074-1076
12. Walford S, Gale EA, Allison SP, Tattersall RB. Self-monitoring of blood-glucose. Improvement of diabetic control. Lancet 1978;1:732-735
13. American Diabetes Association (ADA). Consensus statement on self-monitoring of blood glucose. Diabetes Care 1987;10: 95-99
14. American Diabetes Association (ADA). Consensus statement on self-monitoring of blood glucose. Diabetes Care 1991; 14(Suppl 2):57-62.
15. American Diabetes Association (ADA). Consensus statement on self-monitoring of blood glucose. Diabetes Care 1994; 17(Suppl 1):81-86
16. Center for Devices and Radiological Health (CDRH). Human factors in self-monitoring of blood glucose. Task IV report. Vol.1. Rockville, MD: Food and Drug Administration, April 1990.
17. The National Steering Committee for Quality Assurance in Capillary Blood Glucose Monitoring. Proposed strategies for reducing user error in capillary blood glucose monitoring. Diabetes Care 1993;16:493-498
18. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, Mc- Donald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;48:436-472 (Pubitemid 34174577)
19. Skeie S, Thue G, Nerhus K, Sandberg S. Instruments for selfmonitoring of blood glucose: comparisons of testing quality achieved by patients and a technician. Clin Chem 2002;48: 994-1003.
20. Balion C, Grey V, Ismaila A, Blatz S, Seidlitz W. Screening for hypoglycemia at the bedside in the neonatal intensive care unit (NICU) with the Abbott PCx glucose meter. BMC Pediatr 2006;6:28.
21. Kost GJ, Vu HT, Lee JH, Bourgeois P, Kiechle FL, Martin C, et al. Multicenter study of oxygen-insensitive handheld glucose point-of-care testing in critical care/hospital/ambulatory patients in the United States and Canada. Crit Care Med 1998; 26:581-590
22. Louie RF, Tang Z, Sutton DV, Lee JH, Kost GJ. Point-of-care glucose testing: effects of critical care variables, influence of reference instruments, and a modular glucose meter design. Arch Pathol Lab Med 2000;124:257-266
23. Price Jr. ME, Hammett-Stabler C, Kemper GB, Davis MG, Piepmeier EH Jr. Evaluation of glucose monitoring devices in the hyperbaric chamber. Mil Med 1995;160:143-146
24. Tang Z, Du X, Louie RF, Kost GJ. Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer wsee commentsx. Am J Clin Pathol 2000;113: 75-86. (Pubitemid 30217342)
25. Tang Z, Du X, Louie RF, Kost GJ. Effects of pH on glucose measurements with handheld glucose meters and a portable glucose analyzer for point-of-care testing. Arch Pathol Lab Med 2000;124:577-582 (Pubitemid 30210991)
26. Tang Z, Lee JH, Louie RF, Kost GJ. Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing wsee commentsx. Arch Pathol Lab Med 2000;124:1135-1140 (Pubitemid 30650312)
27. Velazquez FR, Bartholomew D. Effect of small sample volume on five glucose monitoring systems. Diabetes Care 1996; 19:903-904
28. Wiener K. The effect of haematocrit on reagent strip tests for glucose. Diabet Med 1991;8:172-175
29. Albertson C, Davis C, Ellison J, Chu C. Clinical evaluation of a new, miniaturized biosensor for self-monitoring of blood glucose. Clin Chem 1998;44:2056-2057
30. Bradley C, Moses JL. Evaluation of blood glucose measurement techniques: locating sources of error. Diabetes Res 1986; 3:53-58
31. Harrison B, Markes R, Bradley P, Ismail IA. A comparison of statistical techniques to evaluate the performance of the glucometer elite blood glucose meter. Clin Biochem 1996;29: 521-527
32. Kimberly MM, Vesper HW, Caudill SP, Ethridge SF, Archibold E, Porter KH, et al. Variability among five over-thecounter blood glucose monitors. Clin Chim Acta 2006;364: 292-297
33. Kristensen GB, Christensen NG, Thue G, Sandberg S. Between-lot variation in external quality assessment of glucose: clinical importance and effect on participant performance evaluation. Clin Chem 2005;51:1632-1636
34. Sacks D. Carbohydrates. In: Burtis CA, Tietz NW, Ashwood ER, editors. Tietz textbook of clinical chemistry, 4th ed. Philadelphia: Saunders, 2006:777-785
35. Flore KM, Delanghe JR. Analytical interferences in point-ofcare testing glucometers by icodextrin and its metabolites: an overview. Perit Dial Int 2009;29:377-383
36. Hones J, Muller P, Surridge N. The technology behind glucose meters: test stripes. Diabetes Technol Ther 2008;10(Suppl 1):S-10-26.
37. Olsthoorn AJ, Duine JA. On the mechanism and specificity of soluble, quinoprotein glucose dehydrogenase in the oxidation of aldose sugars. Biochemistry 1998;37:13854-13861
38. Durst R, Siggard-Andersen O. Electrochemistry. In: Burtis CA, Ashwood ER, editors. Tietz textbook of clinical chemistry, 3rd ed. Philadelphia: Saunders, 1999:133-149
39. Kristensen GB, Monsen G, Skeie S, Sandberg S. Standardized evaluation of nine instruments for self-monitoring of blood glucose. Diabetes Technol Ther 2008;10:467-477
40. Feldman B, McGarraugh G, Heller A, Bohannon N, Skyler J, DeLeeuw E, et al. FreeStyle: a small-volume electrochemical glucose sensor for home blood glucose testing. Diabetes Technol Ther 2000;2:221-229
41. Kilpatrick ES, Rumley AG, Myint H, Dominiczak MH, Small M. The effect of variations in haematocrit, mean cell volume and red blood cell count on reagent strip tests for glucose. Ann Clin Biochem 1993;30:485-487
42. Goudable J, Pollet J, DuBois JA. wInaccuracy of glucose meters. Automatic correction for hematocrit variations and the presence of exogenous interfering componentsx. Ann Biol Clin (Paris) 2008;66:647-655
43. Rao LV, Jakubiak F, Sidwell JS, Winkelman JW, Snyder ML. Accuracy evaluation of a new glucometer with automated hematocrit measurement and correction. Clin Chim Acta 2005;356:178-183
44. Kristensen GB, Nerhus K, Skeie S, Sandberg S. Quality assurance of self-monitoring of blood glucose at the general practitioner's office. Point Care 2006;5:100-104
45. American Diabetes Association (ADA). Standards of medical care in diabetes. Diabetes Care 2008;31(Suppl):S12-54.
46. Bina DM, Anderson RL, Johnson ML, Bergenstal RM, Kendall DM. Clinical impact of prandial state, exercise, and site preparation on the equivalence of alternative-site blood glucose testing. Diabetes Care 2003;26:981-985
47. Ellison JM, Stegmann JM, Colner SL, Michael RH, Sharma MK, Ervin KR, et al. Rapid changes in postprandial blood glucose produce concentration differences at finger, forearm, and thigh sampling sites. Diabetes Care 2002;25:961-964
48. Johnson RN, Baker JR. Error detection and measurement in glucose monitors. Clin Chim Acta 2001;307:61-67
49. Karter AJ, Ackerson LM, Darbinian JA, D'Agostino RB Jr, Ferrara A, Liu J, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser permanente diabetes registry. Am J Med 2001;111:1-9.
50. Murata GH, Shah JH, Hoffman RM, Wendel CS, Adam KD, Solvas PA, et al. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care 2003;26:1759-1763
51. Davidson MB. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: response to Welschen et al. and Kleefstra et al. Diabetes Care 2005;28: 2597; author reply 2597-2598
52. Davidson MB. Counterpoint: self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care 2005;28:1531-1533
53. Davis WA, Bruce DG, Davis TM. Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes Study. Diabetologia 2007;50:510-515
54. Davis WA, Norman PE, Bruce DG, Davis TM. Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 2006;49:2634-2641
55. Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. Br Med J 2007;335:132.
56. Franciosi M, Pellegrini F, De Berardis G, Belfiglio M, Cavaliere D, Di Nardo B, et al. The impact of blood glucose selfmonitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care 2001;24:1870-1877
57. Harris MI. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care 2001;24:979-982
58. Heller SR. Self monitoring of blood glucose in type 2 diabetes. Br Med J 2007;335:105-106
59. Karter AJ, Moffet HH, Liu J, Parker MM, Ahmed AT, Go AS, et al. Glycemic response to newly initiated diabetes therapies. Am J Manag Care 2007;13:598-606.
60. Karter AJ, Parker MM, Moffet HH, Ahmed AT, Chan J, Spence MM, et al. Effect of cost-sharing changes on selfmonitoring of blood glucose. Am J Manag Care 2007;13: 408-416
61. Karter AJ, Parker MM, Moffet HH, Spence MM, Chan J, Ettner SL, et al. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care 2006;29: 1757-1763
62. Martin S, Heinemann L, Scherbaum WA, Kolb H. Reply to comment on: Martin S, Schneider B, Heinemann L, et al. (2006). Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006;49:271-278
63. McGeoch G, Derry S, Moore RA. Self-monitoring of blood glucose in type-2 diabetes: what is the evidence? Diabetes Metab Res Rev 2007;23:423-440
64. Peel E, Douglas M, Lawton J. Self monitoring of blood glucose in type 2 diabetes: longitudinal qualitative study of patients' perspectives. Br Med J 2007;335:493.
65. Saudek CD, Derr RL, Kalyani RR. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. J Am Med Assoc 2006;295:1688-1697
66. Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 2005;28:1510-1517 (Pubitemid 40756728)
67. Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin. Cochrane Database Syst Rev 2005:CD005060.
68. Klonoff DC, Bergenstal R, Blonde L, Boren SA, Church TS, Gaffaney J, et al. Consensus report of the coalition for clinical research-self-monitoring of blood glucose. J Diabetes Sci Technol 2008;2:1030-1053
69. Bergenstal RM, Gavin JR 3rd. The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. Am J Med 2005;118(Suppl 9A): 1S-6S.
70. International Diabetes Federation. Global guideline for type 2 diabetes. www.idf.org (Accessed 24th November 2006).
71. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM, et al. Tests of glycemia in diabetes. Diabetes Care 2004;27:1761-1773
72. Harris MI, Cowie CC, Howie LJ. Self-monitoring of blood glucose by adults with diabetes in the United States population. Diabetes Care 1993;16:1116-1123
73. Center for Disease Control and Prevention (CDC). Self-monitoring of blood glucose among adults with diabetes - United States, 1997-2006. MMWR Morb Mortal Wkly Rep 2007;56: 1133-1137
74. Hansen MV, Pedersen-Bjergaard U, Heller SR, Wallace TM, Rasmussen AK, Jorgensen HV, et al. Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Diabetes Res Clin Pract 2009;85:183-188
75. Frost & Sullivan: Clinical Diagnostics Growth Partnership Service: Strategic Analysis Service. Global In Vitro Diagnostics Market Outlook; F365-52, May 2005.
76. Fraser CG. Quality specifications in laboratory medicine. Clin Biochem Rev 1996;17:109-114
77. Hyltoft Petersen P, Fraser CG, Kallner A, Kenny D. Strategies to set global analytical quality specifications in laboratory medicine. Scand J Clin Lab Invest 1999;59:475-585.
78. Boyd JC, Bruns DE. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin Chem 2001;47:209-214
79. Sandberg S, Thue G. Quality specifications derived from objective analyses based upon clinical needs. Scand J Clin Lab Invest 1999;59:531-534
80. Weiss SL, Cembrowski GS, Mazze RS. Patient and physician analytic goals for self-monitoring blood glucose instruments. Am J Clin Pathol 1994;102:611-615
81. Skeie S, Thue G, Sandberg S. Patient-derived quality specifications for instruments used in self-monitoring of blood glucose. Clin Chem 2001;47:67-73.
82. ISO 15197:2003-2005-1. In vitro diagnostic test systems - requirements for blood glucose monitoring systems for selftesting in managing diabetes mellitus. Reference number ISO:2003 (E). Geneva: International Organization for Standardization, 2003.
83. Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care 2007;30:403-409
84. Koschinsky T, Dannehl K, Gries FA. New approach to technical and clinical evaluation of devices for self-monitoring of blood glucose. Diabetes Care 1988;11:619-629
85. Chen ET, Nichols JH, Duh SH, Hortin G. Performance evaluation of blood glucose monitoring devices. Diabetes Technol Ther 2003;5:749-768
86. Klonoff DC. The need for separate performance goals for glucose sensors in the hypoglycemic, normoglycemic, and hyperglycemic ranges. Diabetes Care 2004;27:834-836
87. Solnica B, Naskalski JW, Sieradzki J. The evaluation of analytical performance of the Precision G point-of-care glucometer. Clin Chem Lab Med 2001;39:1283-1286
88. Trajanoski Z, Brunner GA, Gfrerer RJ, Wach P, Pieber TR. Accuracy of home blood glucose meters during hypoglycemia. Diabetes Care 1996;19:1412-1415
89. Garg SK, Carter JA, Mullen L, Folker AC, Parkes JL, Tideman AM. The clinical performance and ease of use of a blood glucose meter that uses a 10-test disk. Diabetes Technol Ther 2004;6:495-502.
90. Kendall DM, Kaplan RA, Paulson CF, Parkes JL, Tideman AM. Accuracy and utility of a 10-test disk blood glucose meter. Diabetes Res Clin Pract 2005;67:29-35.
91. Kristensen GB, Nerhus K, Thue G, Sandberg S. Standardized evaluation of instruments for self-monitoring of blood glucose by patients and a technologist. Clin Chem 2004;50:1068-1071
92. Lehmann R, Kayrooz S, Greuter H, Spinas GA. Clinical and technical evaluation of a new self-monitoring blood glucose meter: assessment of analytical and user error. Diabetes Res Clin Pract 2001;53:121-128
93. Mahoney J, Ellison J. Assessing the quality of glucose monitor studies: a critical evaluation of published reports. Clin Chem 2007;53:1122-1128
94. Sluss P. Bedside blood glucose testing systems: current technology. Point Care 2006;5:121-125
95. Mohr T, Pfutzner A, Forst S, Forst T, Schondorf T. Self-monitoring of blood glucose levels requires intensive training for use of meters to obtain reliable and clinically relevant measurements. J Diabetes Sci Technol 2007;1:56-61.
96. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987;10:622-628
97. Cox DJ, Richards FE, Gonder-Fredrick LA, Julian DM, Carter WR, Clarke WL. Clarification of error-grid analysis. Diabetes Care 1989;12:235-238
98. Gough DA, Botvinick EL. Reservations on the use of error grid analysis for the validation of blood glucose assays. Diabetes Care 1997;20:1034-1036
99. Stockl D, Dewitte K, Fierens C, Thienpont LM. Evaluating clinical accuracy of systems for self-monitoring of blood glu cose by error grid analysis: comment on constructing the "upper A-line". Diabetes Care 2000;23:1711-1712
100. Moberg E, Lundblad S, Lins PE, Adamson U. How accurate are home blood-glucose meters with special respect to the low glycemic range? Diabetes Res Clin Pract 1993;19:239-243
101. Kost GJ, Tran NK, Abad VJ, Louie RF. Evaluation of pointof- care glucose testing accuracy using locally-smoothed median absolute difference curves. Clin Chim Acta 2008;389:31-39
102. Wood WG, Hanke R, Meissner D, Reinauer H. Experience with an external quality assessment programme for point-ofcare- testing (POCT) devices for the determination of blood glucose. Clin Lab 2003;49:151-159
103. Kristensen GB, Nerhus K, Thue G, Sandberg S. Results and feasibility of an external quality assessment scheme for selfmonitoring of blood glucose. Clin Chem 2006;52:1311-1317
104. Alto WA, Meyer D, Schneid J, Bryson P, Kindig J. Assuring the accuracy of home glucose monitoring. J Am Board Fam Pract 2002;15:1-6.
105. Henry MJ, Major CA, Reinsch S. Accuracy of self-monitoring of blood glucose: impact on diabetes management decisions during pregnancy. Diabetes Educ 2001;27:521-529
106. Schrot RJ, Foulis PR, Morrison AD, Farese RV. A computerized model for home glucose monitoring proficiency testing: efficacy of an innovative testing program. Diabetes Educ 1999;25:48-55.
107. Solnica B, Naskalski JW. Quality control of self-monitoring of blood glucose: why and how? J Diabetes Sci Technol 2007; 1:164-168
108. Kjome RL, Granás AG, Nerhus K, Sandberg S. Quality assessment of patients' self-monitoring of blood glucose in community pharmacies. Pharm Pract 2010. In press.
109. Klonoff DC. A review of continuous glucose monitoring technology. Diabetes Technol Ther 2005;7:770-775
110. CLSI. Performance metrics for continuous interstitial glucose monitoring; approved guideline. CLSI document POCT05-A, Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
111. Jacobsen CE. En modell for evaluering av systemer til kontinuerlig glukosemáling. Utpŕing av Guardian REAL-Time. Master thesis. Bergen: University of Bergen, 2009.